OAM
KALA icon

Oxford Asset Management’s KALA BIO KALA Stock Holding History

Oxford Asset Management’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-11
Closed -$234K – 1847
2019
Q1 		$234K Sell
11
-59
-84% -$1.05M 0.01% 1473
2018
Q4 		$849K Buy
70
+66
+1,650% +$1.14M 0.02% 942
2018
Q3 		$110K Buy
+4
New +$122K ﹤0.01% 1638
2018
Q1 		– Sell
-6
Closed -$260K – 1760
2017
Q4 		$260K Sell
6
-71
-92% -$3.32M 0.01% 1377
2017
Q3 		$4.37M Buy
+77
New +$4.23M 0.08% 261

Other funds holding KALA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Oxford Asset Management's KALA Position: Q2 2019 in Review

Oxford Asset Management sold out of KALA BIO (KALA) in Q2 2019, closing a stake of 11 shares — an estimated $234K sold.

Oxford Asset Management first reported a position in KALA in Q3 2017 and held it in 5 quarters. The position peaked at $4.37M in Q3 2017. 63 funds tracked by Wall St. Rank hold KALA as of Q2 2019.

  • Oxford Asset Management reported no remaining KALA BIO position as of Q2 2019 after selling out during the quarter.
  • Oxford Asset Management sold 11 KALA BIO shares in Q2 2019, an estimated $234K.
  • Oxford Asset Management first reported a position in KALA BIO in Q3 2017 and held it in 5 quarters.
  • Oxford Asset Management's KALA BIO position peaked at $4.37M in Q3 2017.
  • 63 funds tracked by Wall St. Rank held KALA BIO as of Q2 2019.

Based on Oxford Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.